SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Balchem Corporation (BCPC) trades at a trailing P/E of 36.2, forward P/E of 34.0. Trailing earnings yield is 2.77%, forward earnings yield 2.94%. PEG 1.73. Graham Number is $64.76.
Criteria proven by this page:
- VALUE (22/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 34.0 (down from trailing 36.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.73 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 2.77% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 2.94% as earnings recover.
- Analyst consensus target $162.00 (-7.7% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 64/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
22/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BCPC
Valuation Multiples
P/E (TTM)36.2
Forward P/E34.0
PEG Ratio1.73
Forward PEG3.86
P/B Ratio4.45
P/S Ratio5.41
EV/EBITDA21.6
Per Share Data
EPS (TTM)$4.79
Forward EPS (Est.)$5.17
Book Value / Share$38.91
Revenue / Share$32.09
FCF / Share$5.35
Yields & Fair Value
Earnings Yield2.77%
Forward Earnings Yield2.94%
Dividend Yield0.55%
Graham Number$64.76
SharesGrow IV$134.44 (-23.4%)
Analyst Target$162.00 (-7.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
47.6 |
-5.71 |
5.12 |
4.82 |
0.40% |
| 2017 |
28.7 |
0.48 |
4.18 |
4.34 |
0.47% |
| 2018 |
32.2 |
-2.44 |
3.65 |
3.93 |
0.53% |
| 2019 |
41.0 |
25.01 |
4.39 |
5.07 |
0.46% |
| 2020 |
43.8 |
7.24 |
4.48 |
5.27 |
0.45% |
| 2021 |
56.5 |
4.25 |
6.19 |
6.80 |
0.34% |
| 2022 |
37.1 |
3.57 |
4.17 |
4.15 |
0.53% |
| 2023 |
44.0 |
16.09 |
4.53 |
5.18 |
0.48% |
| 2024 |
41.0 |
2.35 |
4.58 |
5.53 |
0.49% |
| 2025 |
32.3 |
1.54 |
3.98 |
4.82 |
0.57% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.75 |
$553.2M |
$55.97M |
10.1% |
| 2017 |
$2.79 |
$594.79M |
$90.07M |
15.1% |
| 2018 |
$2.42 |
$643.68M |
$78.57M |
12.2% |
| 2019 |
$2.45 |
$643.71M |
$79.67M |
12.4% |
| 2020 |
$2.60 |
$703.64M |
$84.62M |
12% |
| 2021 |
$2.94 |
$799.02M |
$96.1M |
12% |
| 2022 |
$3.25 |
$942.36M |
$105.37M |
11.2% |
| 2023 |
$3.35 |
$922.44M |
$108.54M |
11.8% |
| 2024 |
$3.93 |
$953.68M |
$128.48M |
13.5% |
| 2025 |
$4.75 |
$1.04B |
$154.85M |
14.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$5.17 |
$4.82 – $5.38 |
$1.1B |
$1.09B – $1.12B |
3 |
| 2027 |
$5.47 |
$5.03 – $5.83 |
$1.16B |
$1.13B – $1.2B |
3 |
| 2028 |
$0.00 |
$0.00 – $0.00 |
$1.21B |
$1.19B – $1.25B |
1 |
| 2029 |
$0.00 |
$0.00 – $0.00 |
$1.27B |
$1.25B – $1.31B |
1 |
